Lirum Therapeutics, Inc. (LRTX)

Lirum Therapeutics will go public soon, but the exact IPO date is still unknown.

IPO Price

$5.00

Shares Offered

5,000,000

Deal Size

$25.00M

Lirum Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Income	-2.19	-2.19	-1.91
Net Income	2.2	2.2	1.92

Cash & Debt

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	4.01	4.01	0.17
Total Debt	0	0	0.5
Net Cash (Debt)	4.01	4.01	-0.33
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-2.24	-2.24	-0.31
Free Cash Flow	-2.24	-2.24	-0.31
Free Cash Flow Growth	-	-	-